MRI to Assess the Effect of Terlipressin in Patients With Acute Hepatorenal Syndrome (HRS-AKI)

CompletedOBSERVATIONAL

Enrollment

Participants

Timeline

Start Date

January 8, 2018

Primary Completion Date

April 15, 2021

Study Completion Date

April 21, 2021

Conditions

Hepato-Renal SyndromePortal HypertensionAcute Kidney InjuryLiver DiseasesLiver CirrhosesCirrhosis CardiacCirrhosis

Trial Locations (2)

Hvidovre University Hospital, Hvidovre

Centre of Gastroenterology, Dept. of medicine. Hvidovre University Hospital, Hvidovre

All Listed Sponsors

lead

Hvidovre University Hospital

OTHER

NCT03483272 - MRI to Assess the Effect of Terlipressin in Patients With Acute Hepatorenal Syndrome (HRS-AKI) | Biotech Hunter | Biotech Hunter